Indegene Limited (BOM:544172)
India flag India · Delayed Price · Currency is INR
551.70
+5.75 (1.05%)
At close: May 9, 2025
-4.22%
Market Cap 136.80B
Revenue (ttm) 28.39B
Net Income (ttm) 4.07B
Shares Out n/a
EPS (ttm) 17.02
PE Ratio 33.64
Forward PE 28.33
Dividend n/a
Ex-Dividend Date n/a
Volume 3,984
Average Volume 11,731
Open 530.05
Previous Close 545.95
Day's Range 530.05 - 554.65
52-Week Range 468.90 - 736.60
Beta n/a
RSI 54.69
Earnings Date Apr 28, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor... [Read more]

Industry Commercial Physical and Biological Research
Founded 1998
Employees 4,367
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544172
Full Company Profile

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.

Financial Statements

News

There is no news available yet.